oxazolidinone bromohydrins, in which benzyl a,b-epoxy esters
are formed.3
In conclusion, we have demonstrated that carboxthioimides
are very versatile and useful carboxy-protecting groups.
Significantly, the thioimide transesterification via DMAP
catalysis provides the acids or various ester protecting groups
without danger of racemization. The successful control of
oxazolidinethione deacylation vs. cyclization of nucleophiles
with bromohydrin aldol adducts illustrates the power of our
newly developed DMAP-promoted nucleophilic cleavage.
Further details in this area will be forthcoming.
We thank the National Science Council of the Republic of
China for support of this work (NSC 88-2213-M-005-006).
Notes and references
‡ Selected data for 3f: dH(400 MHz, CDCl3) 6.22 (dd, J 5.6, 3.2, 1H,
CHNCH), 5.96 (dd, J 5.6, 2.8, 1H, CHNCH), 4.07 (m, 2H, OCH2CH2), 3.06
(m, 1H, HCCNC), 2.43 (m, 1H, CNCCH), 2.31 (dd, J 4.0, 4.0, 1H, HCCNO),
1.79 (m, 1H, HCCH3), 1.37–1.52 (m, 2H, H2CCH), 1.14 (d, J 7.2, 3H,
CHCH3), 0.92 [m, 2H, CH2CH2Si(CH3)3], 0.01 [s, 9H, Si(CH3)3]; dC(100
MHz, CDCl3) 174.97, 138.59, 133.21, 62.31, 52.60, 48.79, 45.96, 45.90,
37.71, 20.96, 17.30, 21.50 (HRMS: calc. for C14H24O2Si, 252.1546. Found
252.1545. Calc. for C14H24O2Si: C, 66.62; H, 9.58. Found: C, 66.40; H,
9.69%). For 8: dH(400 MHz, CDCl3) 7.35 (br s, 5H, C6H5), 5.20 (2d, J 12.0,
2H, C6H5CH2), 4.47 (d, J 3.6, 1H, CHCHBr), 3.53 (dd, J 7.2, 3.6, 1 H,
Scheme 2
but still in excellent yield (Scheme 2). After 72 h, the
transesterification product 5, [a]2D5 +129.3 (c 0.9, CH2Cl2),9 was
obtained in 95% with no detectable levels of epimerization.
Using the above standard conditions, both hydrolysis and
methanolysis of aldol adduct 6 were easily effected without
racemization of either center (Scheme 3). The acid 6a, [a]D25
+13.6 (c 1.1, CH2Cl2), and ester 6b, [a]2D5 +22.5 (c 1.4,
CH2Cl2),2 were obtained in 87 and 92% yield, respectively.
CHCHCHBr), 1.87 (br s, 1H, OH), 1.78 (app. octet,
J 7.2, 1H,
(CH3)2CHCH), 1.00 (d, J 6.8, 3H, CH3CHCH3), 0.91 (d, J 6.8, 3H,
CH3CHCH3); dC(100 MHz, CDCl3) 169.18, 134.67, 128.60, 128.48,
128.25, 75.91, 67.94, 51.07, 31.61, 18.90, 17.60; [a]2D5 +15.5 (c 0.9,
CH2Cl2) (HRMS: calc. for C13H17O3Br, 300.0361. Found, 300.0355. Calc.
for C13H17O3Br: C, 51.82; H, 5.69. Found: C, 51.80; H, 5.65%).
1 Selected reviews: D. A. Evans, J. V. Nelson and T. R. Taber, Top.
Stereochem., 1982, 13, 1; C. H. Heathcock, in Asymmetric Synthesis, ed.
J. D. Morrison, Academic Press, New York, 1984, vol. 3, p. 111.
2 D. A. Evans, J. Bartrol and T. L. Shih, J. Am. Chem. Soc., 1981, 103,
2127.
3 A. Abdel-Magid, N. P. Lendon, S. E. Drake and L. Ivan, J. Am. Chem.
Soc., 1986, 108, 4595.
4 H. Heathcock, Aldrichim. Acta, 1990, 23, 99 and references cited
therein; M. P. Bonner and E. R. Thornton, J. Am. Chem. Soc., 1991, 113,
1299; Y.-C. Wang, A.-W. Hung, C.-S. Chang and T.-H. Yan, J. Org.
Chem., 1996, 61, 2038.
5 T.-H. Yan, C.-W. Tan, H.-C.Lee, H.-C. Lo and T.-Y. Huang, J. Am.
Chem. Soc., 1993, 115, 2613; T.-H. Yan, A.-W. Hung, H.-C. Lee and
C.-S. Chang, J. Org. Chem., 1994, 59, 8187; T.-H. Yan, A.-W.Hung,
H.-C. Lee, C.-S. Chang and W.-H. Liu, J. Org. Chem., 195, 60, 3301.
6 C.-N. Hsiao, L. Liu and M. J. Miller, J. Org. Chem., 1987, 52, 2201.
7 D. A. Evans, M. D. Ennis and D. J. Mathre, J. Am. Chem. Soc., 1982,
104, 1737; D. A. Evans, M. M. Morrissey and R. L. Dorow, J. Am.
Chem. Soc., 1985, 107, 4346; D. A. Evans, J. A. Ellman and R. L.
Dorow, Tetrahedron Lett., 1987, 28, 1123; D. A. Evans, T. C. Britton
and J. A. Ellman, Tetrahedron Lett., 1987, 28, 6141.
8 G. Hofle, W. Steglich and H. Vorbruggen, Angew. Chem., Int. Ed. Engl.,
1978, 17, 569; B. Neises and W. Steglich, Angew. Chem., Int. Ed. Engl.,
1978, 17, 522.
9 D. A. Evans, K. T. Chapman and J. Bisaha, J. Am. Chem. Soc., 1988,
110, 1238.
Scheme 3
In conjunction with a program directed toward the asym-
metric synthesis of b-hydroxy-a-amino acids, a key inter-
mediate toward biologically active peptides and b- and g-lactam
antibiotics,12 we were particularly interested in bromohydrin
substrates.13 To demonstrate the utility of this protocol, we
examined the transesterification of bromohydrin aldol 7,14
which by virtue of the ease of bromide displacement demands
very mild methods. In the DMAP (0.2 equiv.) catalyzed
transesterification (PhCH2OH) of bromohydrin 7 at 0 °C,
epoxide formation was completely suppressed and benzyl b-
hydroxy-a-amino ester 8 was isolated in 96% yield with no
apparent loss of stereochemistry (Scheme 4).‡ This result is in
directed contrast to the BnOLi deacylation conditions for
10 D. A. Evans, S. J. Miller and T. Lectka, J. Am. Chem. Soc., 1993, 115,
6460.
11 New compounds have been satisfactorily characterized spectroscop-
ically, and elemental composition has been established by high-
resolution mass spectroscopy and/or combustion analysis.
12 Amino Acids, Peptides and Proteins, Specialist Periodical Reports, vol.
1–16, ed. G. T. Young and R. C. Sheppard, Chemistry Society, London,
1968–1983; T. Sunazuka, T. Nagamitsu, K. Matsuzaki, H. Tanaka, S.
Omura and A. B. Smith, III, J. Am. Chem. Soc., 1993, 115, 5302.
13 D. A. Evans, E. B. Sjogren, A. E. Weber and R. E. Conn, Tetrahedron
Lett., 1987, 28, 39; E. J. Corey, D.-H. Lee and S. Choi, Tetrahedron
Lett., 1992, 33, 6735.
14 Prepared from the TiCl4-mediated aldolization of camphor-based
3-bromoacetyl-1,3-oxazolidine-2-thione with isobutyraldehyde.
Scheme 4
Communication 9/00577C
546
Chem. Commun., 1999, 545–546